Sofia Haselgruber
Granada, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Limited Effectiveness of IL-17 Inhibitors for Anti-TNF-Induced Psoriasis in Hidradenitis Suppurativa: A Multicenter Retrospective Study.
Journal: International journal of dermatology
Published: December 27, 2025
Assessing Disease Progression in Hurley I Hidradenitis Suppurativa Patients: A Nested Case-Control Study.
Journal: Dermatology (Basel, Switzerland)
Published: July 14, 2025
Potential clinical factors associated with secukinumab dose selection in the treatment of hidradenitis suppurativa: a cohort study of 132 patients.
Journal: The Journal of dermatological treatment
Published: June 27, 2025
Impact of Vitiligo on Major Life-changing Decisions and Perceived Stigmatization: A Cross-sectional Study.
Journal: Acta dermato-venereologica
Published: June 23, 2025
Real World Evidence of Secukinumab and Bimekizumab in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis.
Journal: Actas dermo-sifiliograficas
Published: January 14, 2025
Real-World Experience With Secukinumab for Hidradenitis Suppurativa: A Multicenter Retrospective Analysis of 263 Patients From the SECU-SPAIN Study.
Journal: Actas dermo-sifiliograficas
Published: December 30, 2024
Real-World Experience With Secukinumab for Hidradenitis Suppurativa: A Multicenter Retrospective Analysis of 263 Patients From the SECU-SPAIN Study.
Journal: Actas dermo-sifiliograficas
Published: December 30, 2024
Implementation of a Multidisciplinary Medical-Surgical Consultation in Hidradenitis Suppurativa Improves Patient Journey and Time to Surgery.
Journal: Dermatology (Basel, Switzerland)
Published: October 02, 2024
ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa.
Journal: Dermatology (Basel, Switzerland)
Published: August 14, 2024
Therapeutic burden in hidradenitis suppurativa: a cross-sectional study of 557 patients.
Journal: International journal of dermatology
Published: July 14, 2024
Insights into the Window of Opportunity and Outcome Measures in Patients with Moderate to Severe Hidradenitis Suppurativa Treated with Secukinumab: A Real-World Study.
Journal: Dermatology and therapy
Published: May 07, 2024
Clinical characteristics and risk factors for secondary lymphoedema in hidradenitis suppurativa.
Journal: The British journal of dermatology
Published: April 27, 2024
Last Updated: 09/26/2026